| Date Filed | Type | Description |
| 05/22/2023 |
4
| Schaub James (EVP and COO) has filed a Form 4 on RVL Pharmaceuticals plc|
Txns:
| Paid exercise price by delivering 5,577 shares
@ $0.87, valued at
$4.9k
|
|
| 01/26/2023 |
4
| Schaub James (EVP and COO) has filed a Form 4 on RVL Pharmaceuticals plc|
Txns:
| Paid exercise price by delivering 9,608 shares
@ $1.26, valued at
$12.1k
|
|
| 05/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/26/2022 |
4
| Schaub James (EVP and COO) has filed a Form 4 on RVL Pharmaceuticals plc|
Txns:
| Paid exercise price by delivering 9,607 shares
@ $1.13, valued at
$10.9k
|
|
| 12/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/08/2021 |
4
| Schaub James (EVP and COO) has filed a Form 4 on Osmotica Pharmaceuticals plc|
Txns:
| Granted 249,814 options to buy
@ $1.8, valued at
$449.7k
|
|
| 05/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2020 |
4
| Schaub James (EVP and COO) has filed a Form 4 on Osmotica Pharmaceuticals plc|
Txns:
| Granted 73,253 shares
@ $0
Granted 73,253 options to buy
@ $0 |
|
| 01/30/2020 |
4
| Schaub James (EVP and COO) has filed a Form 4 on Osmotica Pharmaceuticals plc|
Txns:
| Paid exercise price by delivering 9,197 shares
@ $7, valued at
$64.4k
|
|
| 01/28/2019 |
4
| Schaub James (EVP and COO) has filed a Form 4 on Osmotica Pharmaceuticals plc|
Txns:
| Granted 104,849 shares
@ $0 |
|
| 10/18/2018 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |